HK196596A - Use of ofloxacin or a salt thereof for preparing a topical preparation for treating otopathy - Google Patents

Use of ofloxacin or a salt thereof for preparing a topical preparation for treating otopathy

Info

Publication number
HK196596A
HK196596A HK196596A HK196596A HK196596A HK 196596 A HK196596 A HK 196596A HK 196596 A HK196596 A HK 196596A HK 196596 A HK196596 A HK 196596A HK 196596 A HK196596 A HK 196596A
Authority
HK
Hong Kong
Prior art keywords
ofloxacin
salt
preparing
topical preparation
otopathy
Prior art date
Application number
HK196596A
Other languages
English (en)
Inventor
Kiichi Sato
Akira Handa
Takeji Kitahara
Original Assignee
Daiichi Pharmceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=13885215&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK196596(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Daiichi Pharmceutical Co Ltd filed Critical Daiichi Pharmceutical Co Ltd
Publication of HK196596A publication Critical patent/HK196596A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
HK196596A 1988-04-08 1996-10-24 Use of ofloxacin or a salt thereof for preparing a topical preparation for treating otopathy HK196596A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63086378A JPH01258620A (ja) 1988-04-08 1988-04-08 耳疾患用局所製剤

Publications (1)

Publication Number Publication Date
HK196596A true HK196596A (en) 1996-11-01

Family

ID=13885215

Family Applications (1)

Application Number Title Priority Date Filing Date
HK196596A HK196596A (en) 1988-04-08 1996-10-24 Use of ofloxacin or a salt thereof for preparing a topical preparation for treating otopathy

Country Status (16)

Country Link
US (1) US5401741A (xx)
EP (1) EP0337328B1 (xx)
JP (2) JPH01258620A (xx)
KR (1) KR0126471B1 (xx)
AT (1) ATE109350T1 (xx)
AU (1) AU614349B2 (xx)
CA (1) CA1330946C (xx)
DE (1) DE68917186T2 (xx)
DK (1) DK175302B1 (xx)
HK (1) HK196596A (xx)
HU (1) HU00407A9 (xx)
IE (1) IE65859B1 (xx)
IL (1) IL89807A (xx)
NZ (1) NZ228632A (xx)
PH (1) PH26367A (xx)
ZA (1) ZA892449B (xx)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5686095A (en) * 1995-10-23 1997-11-11 Price, Jr.; Francis W. Method of treating canker sores
US5753269A (en) * 1995-12-27 1998-05-19 Bayer Corporation Otic microbial combinations
US6248343B1 (en) 1998-01-20 2001-06-19 Ethicon, Inc. Therapeutic antimicrobial compositions
US5972358A (en) * 1998-01-20 1999-10-26 Ethicon, Inc. Low tack lotion, gels and creams
US5997893A (en) * 1998-01-20 1999-12-07 Ethicon, Inc. Alcohol based anti-microbial compositions with cosmetic appearance
US6022551A (en) * 1998-01-20 2000-02-08 Ethicon, Inc. Antimicrobial composition
US5912255A (en) * 1998-02-27 1999-06-15 Bussell; Letantia Topical fluoroquinolone antibiotics combined with benzoyl peroxide
US6017912A (en) * 1998-02-27 2000-01-25 Bussell; Letantia Topical fluoroquinolone antibiotics in an alcohol and acetone vehicle
ATE332692T1 (de) * 1998-08-21 2006-08-15 Kyorin Seiyaku Kk Wässerige flüssige zubereitungen
DE19937116A1 (de) * 1999-08-06 2001-02-08 Bayer Ag Moxifloxacin Kochsalzformulierung
US7064132B2 (en) * 1999-11-28 2006-06-20 Scientific Development And Research, Inc. Composition and method for treatment of otitis external
US6676930B2 (en) 1999-11-28 2004-01-13 Scientific Development And Research, Inc. Composition and method for treatment of otitis media
US6156294A (en) * 1999-11-28 2000-12-05 Scientific Development And Research, Inc. Composition and method for treatment of otitis media
HUP0303696A3 (en) 2000-09-25 2005-05-30 Bayer Healthcare Llc Tarrytown Otic microbial combinations for treatment of animals with ruptured tympanic membrane
US20090215735A1 (en) * 2002-02-25 2009-08-27 Alcon, Inc. Topical solution formulations containing a corticosteroid and a cyclodextrin
ES2552936T3 (es) * 2003-12-12 2015-12-03 Otic Pharma Ltd. Composiciones para el tratamiento del desordenes en el oído y métodos para el uso de los mismos
US8940321B2 (en) 2003-12-12 2015-01-27 Otic Pharma Ltd. Compositions for treatment of ear disorders and methods of use thereof
US8318817B2 (en) 2008-07-21 2012-11-27 Otonomy, Inc. Controlled release antimicrobial compositions and methods for the treatment of otic disorders
CN105682742A (zh) 2013-08-27 2016-06-15 奥德纳米有限公司 小儿耳部病症的治疗
US11040004B2 (en) 2016-09-16 2021-06-22 Otonomy, Inc. Otic gel formulations for treating otitis externa

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4260416A (en) * 1979-09-04 1981-04-07 Allied Chemical Corporation Amorphous metal alloy for structural reinforcement
JPS5746986A (en) * 1980-09-02 1982-03-17 Dai Ichi Seiyaku Co Ltd Pyrido(1,2,3-de)(1,4)benzoxazine derivative
US4551456A (en) * 1983-11-14 1985-11-05 Merck & Co., Inc. Ophthalmic use of norfloxacin and related antibiotics
JPS638333A (ja) * 1986-06-30 1988-01-14 Dai Ichi Seiyaku Co Ltd 外用剤
JP2558107B2 (ja) * 1986-12-18 1996-11-27 第一製薬株式会社 外用剤
CA1309024C (en) * 1986-12-19 1992-10-20 Hiromitsu Seki Aqueous pharmaceutical composition containing s-(-)-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl -7-oxo-2,3,-dihydro-7h-pyridol[1,2,3,-de][1,4]benzoxazine -6-carboxylic acid

Also Published As

Publication number Publication date
KR890015742A (ko) 1989-11-25
PH26367A (en) 1992-06-01
JP2573351B2 (ja) 1997-01-22
ZA892449B (en) 1989-12-27
IL89807A (en) 1993-08-18
JPH01258620A (ja) 1989-10-16
AU614349B2 (en) 1991-08-29
DK168189D0 (da) 1989-04-07
AU3256789A (en) 1989-10-12
NZ228632A (en) 1991-10-25
IE65859B1 (en) 1995-11-29
IE891118L (en) 1989-10-08
CA1330946C (en) 1994-07-26
DE68917186D1 (de) 1994-09-08
JPH0334925A (ja) 1991-02-14
DK168189A (da) 1989-10-09
EP0337328A3 (en) 1991-12-27
ATE109350T1 (de) 1994-08-15
DE68917186T2 (de) 1995-01-05
US5401741A (en) 1995-03-28
DK175302B1 (da) 2004-08-16
KR0126471B1 (ko) 1997-12-24
HU00407A9 (en) 1995-09-28
EP0337328B1 (en) 1994-08-03
EP0337328A2 (en) 1989-10-18

Similar Documents

Publication Publication Date Title
HK196596A (en) Use of ofloxacin or a salt thereof for preparing a topical preparation for treating otopathy
PT80349A (en) Process for the preparation of 1,4-dihydro-4-oxonaphthyridine derivatives and salts thereof and of antibacterial agents comprising the same
HU199285B (en) Process for producing topical antihypertenzive ophthalmic compositioncontaining 2,5-dihydroxy-6-isopropyl-amino-5,6,7,8-tetrahydro-1-naphtyl-methanol or salts
ZA874769B (en) Calcium salts
GB8917385D0 (en) Process for the preparation of nylon salts
FI894546A (fi) Menetelmä uusien 2'-halogeenimetylideeni-, 2'-etenylideeni- ja 2'-etynyyliadenosiinijohdannaisten valmistamiseksi
PT81274B (en) Process for the preparation of substituted 2-furanylalkoxyalkylcyclimmonium or 5-oxo-2-furanylalkoxyalkycyclimmonium salts
EP0444564A3 (en) Direct process for the preparation of activated antiperspirant salts
GB8719583D0 (en) Controlling angular position of implement
GR3003709T3 (xx)
YU132088A (en) 4-amino-substituted derivatives of 1,2-dihydronaphtaline
ZA886247B (en) Use of a compound for the treatment of schizophrenia
EP0430552A3 (en) Treatment of pulmonary dysfunction with 15-keto-prostaglandin compounds
EP0303232A3 (en) Use of benzylpyridine derivatives for the treatment of dementia
EP0334097A3 (en) Process for the preparation of 4,4'-dihalogeno-bisphenyls
EP0297496A3 (en) Novel process for the preparation of 6,7-diacyl-7-deacetylforskolin derivatives
PT83884A (en) Process for the preparation of 1 azolyl-3,3-dimethyl-tutan-2-on-and-ol derivatives
ZA895888B (en) Novel derivatives of 6,11-dihydro-dibenzol(c,f)(1,2,5)thiadiazepine 5,5-dioxide,salts thereof and appropriate processes for the preparation thereof
ZA913920B (en) Therapeutic compound
PT85518A (en) Process for the preparation of antibacterial 7-oxo-4-thia-1-aza-bicyclo ]3.2.o" hept-2-ene derivatives
EP0310259A3 (en) Eperisone as a hypotensive agent
EP0350293A3 (en) Process for preparing derivatives of 2'-deoxy-beta-cytidine and salts thereof
EP0347021A3 (en) Process for the preparation of 2,3-dimethoxy-5-methylbenzoquinone
ZA844114B (en) 6(or 5)-hydroxybenzothiazole-2-sulfonamide-o-sulfate salts for the topical treatment of elevated intraocular pressure
EP0373216A4 (en) Cephalosporin compounds or their salts, process for their preparation, and parmaceutical compositions

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20090406